The crystal structures of the 1:1 complexes methylguanidinium benzylhydrogenmalonate, (C2N3H8)+(C10H9O4)−, MGD.BMAL, and methylguanidinium ethylhydrogenmalonate, (C2N3H8)+(C5H7O4)−, MGD.EMAL, and of the 2:1 complex methylguanidinium sulfate, (C2N3H8)2SO4, have been determined from three‐dimensional X‐ray data. For MGD.BMAL, the complex crystallizes in the triclinic space group P with two formula units in a cell of dimensions a = 6.277(5), b = 8.470(3), c = 13.191(6)Å, α= 91.01(1), β= 99.64(9), γ= 90.83(5)°. The structure has been refined to a final value of R = 0.061 based on 1511 intensities. The MGD.EMAL complex is also triclinic, space group P with two molecules in a cell of dimensions a = 9.254(7), b = 9.625(6), c = 6.778(2) Å, α= 109.6(1), β= 100.8(1), γ= 62.7(1)Å. The crystals of this compound are of low quality, and the final value is R = 0.109 based on 706 intensities. (MGD)2SO4 is orthorhombic, space group P212121, with four molecules in a cell of dimensions a = 7.100(4), b = 12.151(3), c = 13.108(2) Å. Refinement has converged to R = 0.054 based on 907 data. All three crystals exhibit extensive interionic hydrogen bonding. The hydrogen bonding in MGD.BMAL includes a Type B interaction and a Type 1 interaction, the latter being a pairwise interaction from both amino nitrogen atoms on the cation to two carboxylate oxygen atoms from the two different carboxylate groups in an anion. In MGD.EMAL, the anion participates in both a Type A and a Type B pairwise interaction with two neighboring cations. The possible implications of the hydrogen bonding patterns in these two compounds for the role of arginyl side chains in protection of γ‐carboxyglutamate residues from decarboxylation are discussed.
No takes yet. Share an insight, caveat, or question.
Yokomori et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: